Meta-analysis of the prognostic role of HE4 expression in cancer patients

Clinical insights into interpretation of clinical outcomes

Rama Jayaraj, Chellan Kumarasamy

Research output: Contribution to journalLetterResearchpeer-review

Abstract

An article titled, “Prognostic values of HE4 expression in patients with cancer: a metaanalysis”, was recently published in the journal, Cancer Management and Research, detailing a study conducted by Dai et al.1 This study aims to validate and estimate the effectiveness of HE4 as a prognostic marker in cancer. We commend the authors for the study’s focus on all types of cancers, as well as the associated subgroup analysis detailing the results for individual cancer types and population groups. This study is valuable as a guidepost for informing future research on HE4 as a prognostic biomarker to predict the cancer patients’ clinical outcomes. However, there are a few points that require to be addressed regarding the study conducted.
Original languageEnglish
Pages (from-to)1791-1792
Number of pages2
JournalCancer Management and Research
Volume11
DOIs
Publication statusPublished - 21 Feb 2019

Fingerprint

Meta-Analysis
Neoplasms
Population Groups
Biomarkers
Research

Cite this

@article{c2f8b625965d4c53a1c3ca9db6a1df7d,
title = "Meta-analysis of the prognostic role of HE4 expression in cancer patients: Clinical insights into interpretation of clinical outcomes",
abstract = "An article titled, “Prognostic values of HE4 expression in patients with cancer: a metaanalysis”, was recently published in the journal, Cancer Management and Research, detailing a study conducted by Dai et al.1 This study aims to validate and estimate the effectiveness of HE4 as a prognostic marker in cancer. We commend the authors for the study’s focus on all types of cancers, as well as the associated subgroup analysis detailing the results for individual cancer types and population groups. This study is valuable as a guidepost for informing future research on HE4 as a prognostic biomarker to predict the cancer patients’ clinical outcomes. However, there are a few points that require to be addressed regarding the study conducted.",
author = "Rama Jayaraj and Chellan Kumarasamy",
year = "2019",
month = "2",
day = "21",
doi = "10.2147/CMAR.S198253",
language = "English",
volume = "11",
pages = "1791--1792",
journal = "Cancer Management and Research",
issn = "1179-1322",
publisher = "Dove Medical Press Ltd.",

}

Meta-analysis of the prognostic role of HE4 expression in cancer patients : Clinical insights into interpretation of clinical outcomes. / Jayaraj, Rama; Kumarasamy, Chellan.

In: Cancer Management and Research, Vol. 11, 21.02.2019, p. 1791-1792.

Research output: Contribution to journalLetterResearchpeer-review

TY - JOUR

T1 - Meta-analysis of the prognostic role of HE4 expression in cancer patients

T2 - Clinical insights into interpretation of clinical outcomes

AU - Jayaraj, Rama

AU - Kumarasamy, Chellan

PY - 2019/2/21

Y1 - 2019/2/21

N2 - An article titled, “Prognostic values of HE4 expression in patients with cancer: a metaanalysis”, was recently published in the journal, Cancer Management and Research, detailing a study conducted by Dai et al.1 This study aims to validate and estimate the effectiveness of HE4 as a prognostic marker in cancer. We commend the authors for the study’s focus on all types of cancers, as well as the associated subgroup analysis detailing the results for individual cancer types and population groups. This study is valuable as a guidepost for informing future research on HE4 as a prognostic biomarker to predict the cancer patients’ clinical outcomes. However, there are a few points that require to be addressed regarding the study conducted.

AB - An article titled, “Prognostic values of HE4 expression in patients with cancer: a metaanalysis”, was recently published in the journal, Cancer Management and Research, detailing a study conducted by Dai et al.1 This study aims to validate and estimate the effectiveness of HE4 as a prognostic marker in cancer. We commend the authors for the study’s focus on all types of cancers, as well as the associated subgroup analysis detailing the results for individual cancer types and population groups. This study is valuable as a guidepost for informing future research on HE4 as a prognostic biomarker to predict the cancer patients’ clinical outcomes. However, there are a few points that require to be addressed regarding the study conducted.

UR - http://www.scopus.com/inward/record.url?scp=85063425133&partnerID=8YFLogxK

U2 - 10.2147/CMAR.S198253

DO - 10.2147/CMAR.S198253

M3 - Letter

VL - 11

SP - 1791

EP - 1792

JO - Cancer Management and Research

JF - Cancer Management and Research

SN - 1179-1322

ER -